OIA
RCEL icon

Optimum Investment Advisors’s Avita Medical RCEL Stock Holding History

Optimum Investment Advisors’s Portfolio RCEL Stock Details RCEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-600
Closed -$27K – 932
2019
Q4 		$27K Buy
+600
New +$24.9K 0.01% 623

Other funds holding RCEL

BC
Blackcrane Capital Bellevue, Washington $16.3M AUM 19.53% 1-Year Est. Return
OMC
Old Mission Capital Chicago, Illinois $6.3B AUM 14.68% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FC
Financial Consulate Hunt Valley, Maryland $899M AUM 20.23% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
MA
MCF Advisors Covington, Kentucky $2.28B AUM 14.87% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Optimum Investment Advisors's RCEL Position: Q1 2020 in Review

Optimum Investment Advisors sold out of Avita Medical (RCEL) in Q1 2020, closing a stake of 600 shares — an estimated $27K sold.

Optimum Investment Advisors first reported a position in RCEL in Q4 2019 and held it in 1 quarter. The position peaked at $27K in Q4 2019. 36 funds tracked by Wall St. Rank hold RCEL as of Q1 2020.

  • Optimum Investment Advisors reported no remaining Avita Medical position as of Q1 2020 after selling out during the quarter.
  • Optimum Investment Advisors sold 600 Avita Medical shares in Q1 2020, an estimated $27K.
  • Optimum Investment Advisors first reported a position in Avita Medical in Q4 2019 and held it in 1 quarter.
  • Optimum Investment Advisors's Avita Medical position peaked at $27K in Q4 2019.
  • 36 funds tracked by Wall St. Rank held Avita Medical as of Q1 2020.

Based on Optimum Investment Advisors's 13F filing for Q1 2020, filed 21 Apr 2020.